You are here: Industry Insights > Prostate Cancer

News List

UMIT - Private University for Health Sciences Medical Informatics and Technology: Results of a Colla en-cphi.cn
July 04, 2017
A simulation study published in BMC Public Health by researchers of the Tyrolean Health and Life Sciences University UMIT, the Oncotyrol center, the Medical University of Innsbruck and the University of Toronto highlights optimized use of prostate cancer
First prostate cancer patients treated with Augmenix's SpaceOAR Hydrogel in Israel cphi-online
July 03, 2017
The Chaim Sheba Medical Center now offers the hydrogel spacer to reduce side-effects during prostate cancer radiation therapy.
Latest prostate cancer research could provide boost for J&J June 06, 2017
Research funded by Cancer Research UK has found that abiraterone added to hormone therapy improved survival by over a third in those suffering from prostate cancer. The trial involved Johnson & Johnson’s Zytiga and could become a new standard of treatment
Early MRI may lower costs for prostate cancer treatment europeanpharmaceuticalreview
May 26, 2017
A diagnostic MRI followed by one of three MRI-guided biopsy strategies is a cost-effective method to detect prostate cancer, according to a new study out of Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Cent
Dendreon eyes real-world data boost for lagging prostate cancer med Provenge fiercepharma
May 16, 2017
Years after winning a hotly anticipated FDA approval for its cancer immunotherapy Provenge—and struggling to build sales of the prostate cancer med—Dendreon has racked up some real-world survival data it hopes can help.
Italian-style coffee reduces the risk of prostate cancer worldpharmanews
April 28, 2017
Add another typical component of the Italian way of life to the long list of foods characterizing one of the most healthy populations in the world.
Is MRI the 'Mammography' of Prostate Cancer Screening? drugs.com
March 27, 2017
MRI screening might greatly reduce overdiagnosis and overtreatment of prostate cancer in older men, a preliminary study suggests.
Combination immunotherapy shows promise in castration-resistant prostate cancer pharmafile
March 14, 2017
Researchers at the University of Texas MD Anderson Cancer Center have found that castration-resistant prostate cancer responds well to a combination treatment comprised of immune checkpoint blockades and myeloid-derived suppressor cell (MDSC)-targeting th
Foresee pharmaceuticals announces top-line results from phase 3 registration study in advanced prost pharmaasia
February 21, 2017
Foresee Pharmaceuticals announced top-line result of FP-001 50mg phase 3 clinical trial, an open-label study in subjects with Advanced Prostate Carcinoma

Previous page 1 2 3 4 5 6 7 8 9 10 Next page